Finally we find that CRX is a new sensitive and specific marker for retinoblastoma and pineal parenchymal tumors that should be useful in the diagnostic evaluation of pineal masses when used as part of a panel of immunohistochemical markers including synaptophysin and GFAP. Here, GFAP is linked to pineal parenchymal cell neoplasm.